Showing 759 news articles about Hepatitis C treatment

Filters Content type: Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Hepatitis C treatment

France Reaches Agreement With Gilead To Drop Prices Of Hepatitis C Treatment

Editor's pick
Intellectual Property Watch
3 April 2017
Hepatitis C treatment

New Report Lays Plan to Eliminate 90,000 Hepatitis B and C Deaths by 2030

Editor's pick
National Academies of Science. Technology and Engineering
29 March 2017
Hepatitis C treatment

The 2017 Hepatitis C Community Summit – a key step on the road to elimination

Editor's pick
BMC Blogs Network (blog)
27 March 2017
Access to healthcare

Gilead hepatitis C drug patent faces European challenge

Editor's pick
Reuters
27 March 2017
Access to healthcare

Pharma could take NHS England to court over new delaying tactics

Editor's pick
PharmaPhorum
27 March 2017
Hepatitis C treatment

Optimism About HCV Treatment Comes With Caveats

Editor's pick
Medscape
22 March 2017
Access to healthcare

Drugs costing 8p a day could be hit by 'devastating' NHS rationing plan

Editor's pick
Telegraph
16 March 2017
Hepatitis C treatment

Malaysia: MOH to propose importing generic Hepatitis C meds

Editor's pick
Malay Mail Online
14 March 2017
Hepatitis C treatment

Hepatitis C patients and nurses highlight impact of the virus in new reports

Editor's pick
Hepatitis C Trust
7 March 2017
Hepatitis C treatment

'I bought hepatitis C cure from Bangladesh'

Editor's pick
BBC Health
2 March 2017
Access to healthcare

Hepatitis C drugs re-energize global fight over patents

Editor's pick
Nature
1 March 2017
Hepatitis C treatment

Ukraine signs amicable agreement with Gilead on hepatitis C drug

Editor's pick
Interfax Ukraine
27 February 2017
Hepatitis C treatment

Egypt targets hepatitis C patients for medical tourism

Editor's pick
International Medical Tourism Journal
24 February 2017
Hepatitis C treatment

Messi visits Egypt to promote Hepatitis C treatment

Editor's pick
Daily News Egypt
22 February 2017
Hepatitis C treatment

Deal reduces price of life-saving hepatitis C drugs for Canadians

Editor's pick
The Globe and Mail
22 February 2017
Hepatitis C treatment

SF working on ambitious plan to eliminate hepatitis C

Editor's pick
San Francisco Chronicle
21 February 2017
Hepatitis C treatment

Hepatitis C will be eradicated in Australia by 2026, researchers predict

Editor's pick
ABC Online
21 February 2017
Hepatitis C treatment

HCV eradication in HIV coinfected patients linked to reduced diabetes, chronic renal failure

Editor's pick
Healio
31 January 2017
Hepatitis C treatment

Report Cites Liver Failure Risk With New Hepatitis C Drugs

Editor's pick
Medscape
31 January 2017
Hepatitis C treatment

Final yes from NICE for Gilead’s Epclusa

Editor's pick
Pharma Times
27 January 2017
Hepatitis C treatment

Egypt combats hepatitis C epidemic with state-run scheme

Editor's pick
Financial Times
23 January 2017
Hepatitis C treatment

Japan: Hepatitis C drug fakes found in Nara drugstore chain

Editor's pick
The Japan Times
18 January 2017
Pharmaceutical industry

The U.S. Government Should Buy Gilead For $156 Billion To Save Money On Hepatitis C

Editor's pick
Forbes
17 January 2017
Access to healthcare

Access to highly effective hepatitis C treatment in Portugal: A Community Perspective

Editor's pick
EATG
19 December 2016